1. Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban

   • Wolfgang Mueck
   • Jan Stampfuss
   • Michael Becka

   Review Article Open access 03 September 2013 Pages: 1 - 16

   

2. Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2

   • Sreeneeranj Kasichayanula
   • Xiaoni Liu
   • David W. Boulton

   Review Article 09 October 2013 Pages: 17 - 27

   

3. Pharmacokinetic of Antiepileptic Drugs in Patients with Hepatic or Renal Impairment

   • Gail D. Anderson
   • Shahin Hakimian

   Review Article 13 October 2013 Pages: 29 - 49

4. Evaluation and Optimisation of Current Milrinone Prescribing for the Treatment and Prevention of Low Cardiac Output Syndrome in Paediatric Patients After Open Heart Surgery Using a Physiology-Based Pharmacokinetic Drug–Disease Model

   • Winnie Vogt

   Original Research Article 10 July 2013 Pages: 51 - 72

   

5. A Mechanistic Framework for In Vitro–In Vivo Extrapolation of Liver Membrane Transporters: Prediction of Drug–Drug Interaction Between Rosuvastatin and Cyclosporine

   • M. Jamei
   • F. Bajot
   • K. Rowland-Yeo

   Original Research Article Open access 24 July 2013 Pages: 73 - 87

   

6. Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban

   • Stefan Willmann
   • Corina Becker
   • Wolfgang Mück

   Original Research Article Open access 03 August 2013 Pages: 89 - 102

   

7. The Effect of St John’s Wort on the Pharmacokinetics of Docetaxel

   • Andrew K. L. Goey
   • Irma Meijerman
   • Jan H. M. Schellens

   Original Research Article 26 September 2013 Pages: 103 - 110